Document is current

Any future updates will be listed below

Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation

Crossref DOI link: https://doi.org/10.1007/s00296-017-3910-3

Published Online: 2017-12-20

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark